Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06960005

ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease

Objectives:

This study aims to assess health-related quality of life (QoL) in adults with thyroid hormone disorders and identify modifiable factors to improve QoL in patients with Hashimoto's thyroiditis (HT) and multinodular toxic goiter (MNTG) through an exercise intervention.

Primary Outcome:

1. Assess the impact of a tailored exercise program on health-related QoL in patients with HT and MNTG using the ThyPRO questionnaire.

Secondary Outcomes:

1. Evaluate the need for a screening tool to identify thyroid patients with reduced health-related QoL despite being euthyroid. 2. Assess the impact of the exercise intervention on body composition, strength, and balance function in HT and MNTG patients.

Methods:

The study is a combined cross-sectional survey and randomized controlled trial into the health related QoL in patients diagnosed with thyroid hormone disease. The cross-sectional survey will assess the overall health-related QoL in patients diagnosed with thyroid hormone disease, and help identify eligible participants for the subsequent RCT.

The RCT will evaluate the efficacy of a comprehensive screening and exercise intervention in patients ≥ 65 years diagnosed with HT or MNTG, experiencing reduced health-related QoL.

Participants:

The aim is to recruit 74 patients with HT and 74 patients with MNTG, including 50 participants from each group with reduced health-related QoL (defined in this study as ThyPRO score ≥ 30) and 24 with good health-related QoL (ThyPRO score ≤ 20)

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Thyroid Disease Endocrine System Diseases Goiter Hashimoto's Thyroiditis Hyperthyreosis and Goiter Hypothyroidism Thyroid Diseases

Age range

65 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Diabeteshuset

Gistrup, 9260, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women with minimum 65 years of age, with no upper limit.
  • Verified diagnosis of HT or MNTG
  • Euthyroid for at least 6 months
  • Signed the informed consent

Exclusion criteria

  • Current participation in a structured exercise program or regular physical exercise activity above 5 hours per week
  • Previous experience with rhythm-based multitask exercise.
  • Diagnosed with significant neurological diseases (e.g. Multiple Sclerosis and myasthenia gravis), vestibular diseases or newly orthopedic surgeries (e.g. knee or hip replacement)
  • Fully dependent on walking aids
  • Active malignancy or terminal illness
  • Inability to understand Danish written and/or verbally
  • Having severely impaired cognitive function, defined as a score below 8 on the cognitive assessment "the short orientation-memory-concentration test"
  • Treatment with amiodarone within the last year
  • No changes within the last six months in medications affecting weight or body composition - e.g., GLP-1 electrolyte/fluid balance - e.g., diuretics or corticosteroid
  • Participation in other clinical intervention studies within the last six months

For the cross sectional survey:

Inclusion criteria

  • Men and women with a minimum of 18 years
  • Diagnosis of primary hypothyroidism or primary hyperthyroidism

Treatment and study plan

Rhythm- and Multitask-Based Activity (RYMA) and Activities of Daily Living (ADL)

Other

Participants will engage in one-hour exercise sessions twice weekly for 26 weeks: one day of RYMA training and one day of ADL-based training

Primary outcomes

  1. Change in Health-Related Quality of Life after the Exercise Intervention

    Time frame: 26 weeks and 52 weeks

    The Thyroid-Related Quality of Life Measure questionnaire (ThyPRO) consists of 85 items summarized into 13 scales and one single item measuring the overall impact of thyroid disease on quality of life. It includes questions on symptoms, mood, memory, tiredness, and general health. Each item is rated on a 0-4 Likert scale, with scores transformed to a 0-100 scale; higher scores indicate worse health status.

    The ThyPRO questionnaire wil be used to assess changes in health-related QoL at 26 weeks (post-intervention) and 52 weeks (follow-up).

Secondary outcomes

  1. Changes in Muscle Mass

    Time frame: 26 weeks and 52 weeks

    Full body Dual-Energy X-ray Absorptiometry (DXA) scans will be used to assess changes in muscle mass. These outcomes will evaluate whether the intervention influences muscle quality over time, with comparisons between intervention and control groups

  2. Changes in Fat Mass Distribution

    Time frame: 26 weeks and 52 weeks

    Full-body DXA scans will be used to assess changes in fat mass distribution over time. Comparisons will be made between intervention and control groups

  3. Muscle Strength

    Time frame: 26 weeks and 52 weeks

    Change in muscle strength assessed by handgrip strength and isometric knee extension strength (using a dynamometer).

  4. Balance Function

    Time frame: 26 weeks and 52 weeks

    Change in balance function assessed through Center of Pressure (CoP).

  5. Identification of Patients with Reduced Health-Related Quality of Life

    Time frame: Baseline (Day 1)

    To assess the potential need for future implementation of health-related quality of life (HRQoL) screening in patients with thyroid hormone disease, based on the number of patients identified with reduced HRQoL using the Thyroid-Related Quality of Life Questionnaire (ThyPRO). The ThyPRO includes 85 items across 13 scales and one overall impact item. Scores range from 0 to 100, with higher scores indicating worse health status.

Other outcomes

  1. Improvement in Nerve Function

    Time frame: Baseline, 26 weeks and 52 weeks

    To estimate the change in nerve fiber function by assessing small, large, and autonomic neuropathy using standardized neurophysiological methods following the exercise intervention in patients with HT and MNTG.

  2. Reduction in fall rates

    Time frame: 26 weeks and 52 weeks

    To estimate changes in fall rates in patients aged >65 with HT or MNTG following the RYMA intervention, compared to their baseline measures (self-controls) and to a usual care group (no RYMA).

Sponsors and collaborators

Lead sponsor

Aalborg University Hospital

Other

Collaborators

  • Steno Diabetes Center Nordjylland

Registry information

Official study title

Screening and Exercise Intervention to Improve Muscle Performance, Reduce Risk of Falls, and Enhance Quality of Life in Thyroid Hormone Disease: ThyMoves

Acronym: ThyMoves

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
May 7, 2025
Registry last updated
Apr 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.